Your browser doesn't support javascript.
loading
High SARS-CoV-2 seroprevalence in Karaganda, Kazakhstan before the launch of COVID-19 vaccination.
Kadyrova, Irina; Yegorov, Sergey; Negmetzhanov, Baurzhan; Kolesnikova, Yevgeniya; Kolesnichenko, Svetlana; Korshukov, Ilya; Akhmaltdinova, Lyudmila; Vazenmiller, Dmitriy; Stupina, Yelena; Kabildina, Naylya; Ashimova, Assem; Raimbekova, Aigul; Turmukhambetova, Anar; Miller, Matthew S; Hortelano, Gonzalo; Babenko, Dmitriy.
Afiliação
  • Kadyrova I; Research Centre, Karaganda Medical University, Karaganda, Kazakhstan.
  • Yegorov S; Michael G. DeGroote Institute for Infectious Disease Research, McMaster Immunology Research Centre, Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, Canada.
  • Negmetzhanov B; School of Sciences and Humanities, Nazarbayev University, Nur-Sultan, Kazakhstan.
  • Kolesnikova Y; School of Sciences and Humanities, Nazarbayev University, Nur-Sultan, Kazakhstan.
  • Kolesnichenko S; National Laboratory Astana, Centre for Life Sciences, Nazarbayev University, Nur-Sultan, Kazakhstan.
  • Korshukov I; Research Centre, Karaganda Medical University, Karaganda, Kazakhstan.
  • Akhmaltdinova L; Research Centre, Karaganda Medical University, Karaganda, Kazakhstan.
  • Vazenmiller D; Research Centre, Karaganda Medical University, Karaganda, Kazakhstan.
  • Stupina Y; Research Centre, Karaganda Medical University, Karaganda, Kazakhstan.
  • Kabildina N; Research Centre, Karaganda Medical University, Karaganda, Kazakhstan.
  • Ashimova A; Research Centre, Karaganda Medical University, Karaganda, Kazakhstan.
  • Raimbekova A; Research Centre, Karaganda Medical University, Karaganda, Kazakhstan.
  • Turmukhambetova A; School of Sciences and Humanities, Nazarbayev University, Nur-Sultan, Kazakhstan.
  • Miller MS; School of Sciences and Humanities, Nazarbayev University, Nur-Sultan, Kazakhstan.
  • Hortelano G; Research Centre, Karaganda Medical University, Karaganda, Kazakhstan.
  • Babenko D; Michael G. DeGroote Institute for Infectious Disease Research, McMaster Immunology Research Centre, Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, Canada.
PLoS One ; 17(7): e0272008, 2022.
Article em En | MEDLINE | ID: mdl-35895743
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Diagnostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Asia / Europa Idioma: En Revista: PLoS One Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Diagnostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Asia / Europa Idioma: En Revista: PLoS One Ano de publicação: 2022 Tipo de documento: Article